Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use INVEGA TRINZA safely and effectively. See full prescribing information for INVEGA TRINZA. INVEGA TRINZA ®(paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2006
Medication labelWhy this: Advisory · dailymed-prescription
INVEGA TRINZA (paliperidone palmitate), a 3-month injection, is indicated for the treatment of schizophrenia in patients after they have been adequately treated with INVEGA SUSTENNA (1-month paliperidone palmitate extended-release injectable suspension) for at least four months [see Dosage and Administration (2.2)and Clinical Studies (14)] .
- generic_name
- paliperidone palmitate
- product_names
- paliperidone palmitate
- ndc
- 50458-606, 50458-607, 50458-608, 50458-609, 50458-606-01, 50458-607-01, 50458-608-01, 50458-609-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en